NCT01729559View on ClinicalTrials.gov

Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin

PHASE4CompletedINTERVENTIONAL

Enrollment

495

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions

Venous Thromboembolic DiseaseDeep Vein ThrombosisPulmonary Embolism

Interventions

DRUG

5000 Units unfractionated Heparin Q 8 hr

Venous thromboembolic prophylaxis medication

DRUG

30mg enoxaparin Q12 hr

Venous thromboembolic prophylaxis

Trial Locations (1)

92103

Scripps Mercy Hospital, San Diego

All Listed Sponsors

lead

Scripps Health

OTHER

NCT01729559 - Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin | Biotech Hunter | Biotech Hunter